Solutions

Online inquiry

  •  

Contact us

Phage-Based Microbicide Material Development

Microbicide materials are produced in a variety of forms, including gels, creams, suppositories, films, or sponges or rings that release the active ingredient over time. A number of materials have been tried or shown promise as microbicides formulations. Temperate phages are not suitable for natural phage therapy because they do not lyse all host cells and have been investigated as materials to display active ingredients for targeted therapeutic delivery. Recently, phage engineering has been greatly expanded in biomedical applications, including tissue engineering and drug delivery. Through genetic engineering, the coating covering the surface of the M13 phage is capable of delivering a variety of therapeutic peptides and proteins. The resulting phages can self-assemble nanofibrous network structures that closely resemble the cellular microenvironment. These structures can influence cell fate through biochemical and physical cues that control the matrix. These phages and their matrices may aid in the development of topical therapeutic materials, as phages can deliver a large number of therapeutic molecules without compromising phage integrity.

Schematic of the M13 phage peptide library and gene construction.Fig 1. Schematic of the M13 phage peptide library and gene construction. (Bhattarai S R, et al., 2012)

Our Solutions

At Creative Biolabs, we are committed to developing and delivering innovative antimicrobial materials that will have a meaningful impact on bacterial therapy. For us, this means focusing on the latest scientific advances, other researchers, and advocates to ensure that our novel materials bring value to the treatment of drug-resistant bacteria.

  • Genetic engineering of M13 phage
  • Fluorescent microscopy studies
  • Phage-based microbicide material development process design
  • Phage-based microbicide material development
  • Carrying out and tracking your program
  • Comprehensive and all-round guidance in real time
  • Analysis and interpretation of experimental data
  • Antibacterial activity detection

M13 Phage for Microbicide material Development

We genetically engineered M13 phage to display the desired fusion protein or peptide on its coat surface protein and developed microbicidal materials.

  • The utility of the M13 display platform stems from the ability to encode phage proteins and display peptides at the genomic level.
  • The versatility of the M13 phage is the result of its non-toxicity, self-assembly and specific binding properties.
  • M13 phages are well-defined and can be genetically and chemically modified by phage display technology to reveal functional peptides.
  • Structurally, the M13 phage is cylindrical with a length of 880 nm and a diameter of 6.6 nm.

Our Advantages

Our Advantages
  • We ask tough questions and sometimes get unpopular answers. We remain impartial, which allows us to disagree and exclude emotions from decision-making, and instead base our advocacy on facts.
  • We don't just give advice; we roll up our sleeves and get involved. Experience tells us that participation at all levels throughout the process significantly improves overall project outcomes.
  • We understand the issues you face when developing phage-based microbicide materials, such as phage selection, antimicrobial ability testing of antimicrobial materials, and more. Because we may have encountered similar situations in similar projects in the past and know what will provide the best results.

Creative Biolabs can meet the needs of customers by providing phage-based microbicide materials development solutions on time and on budget. We have in-depth knowledge and experience of the tools and processes involved in phage projects. Our skilled and dedicated scientific researchers ensure that the most suitable methods and techniques are selected for your project. If necessary, please feel free to contact us.

Reference

  • Bhattarai S R, Yoo S Y, Lee S W, et al. Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection[J]. Biomaterials, 2012, 33(20): 5166-5174.

Please kindly note that our services can only be used to support research purposes (Not for clinical use).

Biophage Technology

Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.

Contact Us
  • Global Locations
Privacy Policy | Cookie Policy | Copyright © 2024 Creative Biolabs. All rights reserved.